Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: The 6-month, randomized RISE (Revealing the Impact of Symbicort in reducing Exacerbations in COPD) study-Reference-Cited by-同舟云学术

Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: The 6-month, randomized RISE (Revealing the Impact of Symbicort in reducing Exacerbations in COPD) study

Published:2017-11 Issue: Volume:132 Page:31-41
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Ferguson Gary T.,Tashkin Donald P.,Skärby Tor,Jorup Carin,Sandin Kristina,Greenwood Michael,Pemberton Kristine,Trudo Frank

Funder

AstraZeneca

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference21 articles.

1. Impact of COPD exacerbations on patient-centered outcomes;Cote;Chest,2007

2. Exacerbation frequency and course of COPD;Halpin;Int. J. Chron. Obstruct. Pulmon. Dis.,2012

3. Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial;Beeh;Respir. Res.,2013

4. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease;Soler-Cataluña;Thorax,2005

5. Global Initiative for Chronic Obstructive Lung Disease (GOLD). GOLD Report 2017. http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/. Accessed 16 November, 2016.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intraclass comparison of inhaled corticosteroids for the risk of pneumonia in chronic obstructive pulmonary airway disorder: a network meta-analysis and meta-regression;International Journal of Clinical Pharmacy;2024-04-25

2. Effect of fracture risk in inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis;BMC Pulmonary Medicine;2023-08-17

3. Risk of Fracture and Osteoporosis in Patients With COPD and Inhaled Corticosteroids Treatment;Respiratory Care;2023-08-08

4. LABA/LAMA versus LABA/ICS fixed-dose combinations in the prevention of COPD exacerbations: a modeling analysis of literature aggregate data;European Journal of Clinical Pharmacology;2023-07-29

5. Association of Inhaled Corticosteroids With All-Cause Mortality Risk in Patients With COPD;Chest;2023-01